Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Inflammatory breast cancer (IBC): clues for targeted therapies.

Fernandez SV, Robertson FM, Pei J, Aburto-Chumpitaz L, Mu Z, Chu K, Alpaugh RK, Huang Y, Cao Y, Ye Z, Cai KQ, Boley KM, Klein-Szanto AJ, Devarajan K, Addya S, Cristofanilli M.

Breast Cancer Res Treat. 2013 Jul;140(1):23-33. doi: 10.1007/s10549-013-2600-4. Epub 2013 Jun 21.

2.

Assessment of diagnosis of inflammatory breast cancer cases at two cancer centers in Egypt and Tunisia.

Schairer C, Soliman AS, Omar S, Khaled H, Eissa S, Ayed FB, Khalafallah S, Ayoub WB, Kantor ED, Merajver S, Swain SM, Gail M, Brown LM.

Cancer Med. 2013 Apr;2(2):178-84. doi: 10.1002/cam4.48. Epub 2013 Jan 24.

3.

Anti-tumor effects of Ganoderma lucidum (reishi) in inflammatory breast cancer in in vivo and in vitro models.

Suarez-Arroyo IJ, Rosario-Acevedo R, Aguilar-Perez A, Clemente PL, Cubano LA, Serrano J, Schneider RJ, Martínez-Montemayor MM.

PLoS One. 2013;8(2):e57431. doi: 10.1371/journal.pone.0057431. Epub 2013 Feb 28.

4.

Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.

El-Shinawi M, Mohamed HT, El-Ghonaimy EA, Tantawy M, Younis A, Schneider RJ, Mohamed MM.

PLoS One. 2013;8(2):e55755. doi: 10.1371/journal.pone.0055755. Epub 2013 Feb 13.

6.

Inflammatory breast cancer in north Africa: comparison of clinical and molecular epidemiologic characteristics of patients from Egypt, Tunisia, and Morocco.

Soliman AS, Kleer CG, Mrad K, Karkouri M, Omar S, Khaled HM, Benider AL, Ayed FB, Eissa SS, Eissa MS, McSpadden EJ, Lo AC, Toy K, Kantor ED, Xiao Q, Hampton C, Merajver SD.

Breast Dis. 2011-2012;33(4):159-69. doi: 10.3233/BD-2012-000337.

7.

Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.

Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD.

Breast Cancer Res Treat. 2012 Aug;134(3):1257-68. doi: 10.1007/s10549-012-2133-2. Epub 2012 Jun 26.

8.

Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the Surveillance, Epidemiology, and End Results database, 2000-2007.

Schlichting JA, Soliman AS, Schairer C, Banerjee M, Rozek LS, Schottenfeld D, Harford JB, Merajver SD.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):155-65. doi: 10.1158/1055-9965.EPI-11-0833. Epub 2011 Oct 25.

9.

Ganoderma lucidum (Reishi) inhibits cancer cell growth and expression of key molecules in inflammatory breast cancer.

Martínez-Montemayor MM, Acevedo RR, Otero-Franqui E, Cubano LA, Dharmawardhane SF.

Nutr Cancer. 2011;63(7):1085-94. doi: 10.1080/01635581.2011.601845. Epub 2011 Sep 2.

10.

Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt.

Spencer B, Banerjee M, Omar S, Khaled H, Anwar N, Zaghloul MS, Eissa S, Kleer CG, Dey S, Merajver SD, Soliman AS.

Breast J. 2011 Sep-Oct;17(5):545-7. doi: 10.1111/j.1524-4741.2011.01146.x. Epub 2011 Aug 9. No abstract available.

11.

Patterns of seeking medical care among Egyptian breast cancer patients: relationship to late-stage presentation.

Mousa SM, Seifeldin IA, Hablas A, Elbana ES, Soliman AS.

Breast. 2011 Dec;20(6):555-61. doi: 10.1016/j.breast.2011.07.001. Epub 2011 Jul 31.

12.

Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.

Chaher N, Arias-Pulido H, Terki N, Qualls C, Bouzid K, Verschraegen C, Wallace AM, Royce M.

Breast Cancer Res Treat. 2012 Jan;131(2):437-44. doi: 10.1007/s10549-011-1422-5. Epub 2011 Mar 1.

13.

Clinical and epidemiologic profile of breast cancer in Tanzania.

Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, Dey S, Merajver SD.

Breast Dis. 2010;31(1):33-41. doi: 10.3233/BD-2009-0296.

Items per page

Supplemental Content

Write to the Help Desk